AQR Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,722
| Closed | -$478K | – | 2374 |
|
|
2022
Q2 | $478K | Buy |
15,722
+4,100
| +35% | +$111K | ﹤0.01% | 1703 |
|
|
2022
Q1 | $302K | Sell |
11,622
-4,508
| -28% | -$107K | ﹤0.01% | 1965 |
|
|
2021
Q4 | $329K | Sell |
16,130
-21,536
| -57% | -$413K | ﹤0.01% | 1958 |
|
|
2021
Q3 | $725K | Sell |
37,666
-17,691
| -32% | -$353K | ﹤0.01% | 1717 |
|
|
2021
Q2 | $1.23M | Sell |
55,357
-29,569
| -35% | -$627K | ﹤0.01% | 1492 |
|
|
2021
Q1 | $2.23M | Sell |
84,926
-39,939
| -32% | -$950K | ﹤0.01% | 1153 |
|
|
2020
Q4 | $2.33M | Sell |
124,865
-39,928
| -24% | -$746K | ﹤0.01% | 1093 |
|
|
2020
Q3 | $2.8M | Buy |
164,793
+34,775
| +27% | +$676K | ﹤0.01% | 967 |
|
|
2020
Q2 | $3.03M | Sell |
130,018
-153,309
| -54% | -$2.22M | ﹤0.01% | 977 |
|
|
2020
Q1 | $2.38M | Buy |
283,327
+5,291
| +2% | +$44.5K | ﹤0.01% | 1017 |
|
|
2019
Q4 | $2.72M | Buy |
278,036
+139,496
| +101% | +$1.31M | ﹤0.01% | 1153 |
|
|
2019
Q3 | $1.31M | Buy |
138,540
+37,554
| +37% | +$396K | ﹤0.01% | 1440 |
|
|
2019
Q2 | $1.2M | Buy |
100,986
+38,060
| +60% | +$459K | ﹤0.01% | 1431 |
|
|
2019
Q1 | $1.11M | Buy |
62,926
+13,690
| +28% | +$228K | ﹤0.01% | 1524 |
|
|
2018
Q4 | $855K | Sell |
49,236
-49,694
| -50% | -$848K | ﹤0.01% | 1573 |
|
|
2018
Q3 | $1.47M | Buy |
98,930
+33,189
| +50% | +$515K | ﹤0.01% | 1533 |
|
|
2018
Q2 | $1.04M | Buy |
65,741
+428
| +0.7% | +$6.38K | ﹤0.01% | 1704 |
|
|
2018
Q1 | $928K | Buy |
65,313
+17,785
| +37% | +$263K | ﹤0.01% | 1702 |
|
|
2017
Q4 | $666K | Buy |
47,528
+12,156
| +34% | +$178K | ﹤0.01% | 1819 |
|
|
2017
Q3 | $506K | Buy |
35,372
+14,061
| +66% | +$201K | ﹤0.01% | 1932 |
|
|
2017
Q2 | $336K | Buy |
21,311
+7,252
| +52% | +$104K | ﹤0.01% | 2009 |
|
|
2017
Q1 | $194K | Sell |
14,059
-6,187
| -31% | -$86.5K | ﹤0.01% | 2117 |
|
|
2016
Q4 | $358K | Sell |
20,246
-38,059
| -65% | -$669K | ﹤0.01% | 2016 |
|
|
2016
Q3 | $1.13M | Buy |
58,305
+12,048
| +26% | +$236K | ﹤0.01% | 1678 |
|
|
2016
Q2 | $902K | Sell |
46,257
-6,479
| -12% | -$127K | ﹤0.01% | 1655 |
|
|
2016
Q1 | $1.09M | Buy |
52,736
+34,188
| +184% | +$674K | ﹤0.01% | 1543 |
|
|
2015
Q4 | $380K | Buy |
+18,548
| New | +$356K | ﹤0.01% | 1969 |
|
|
2014
Q4 | – | Sell |
-13,540
| Closed | -$240K | – | 2655 |
|
|
2014
Q3 | $240K | Hold |
13,540
| – | – | ﹤0.01% | 2270 |
|
|
2014
Q2 | $279K | Sell |
13,540
-10,500
| -44% | -$216K | ﹤0.01% | 2239 |
|
|
2014
Q1 | $524K | Buy |
24,040
+2,000
| +9% | +$45.8K | ﹤0.01% | 2008 |
|
|
2013
Q4 | $585K | Hold |
22,040
| – | – | ﹤0.01% | 1989 |
|
|
2013
Q3 | $521K | Buy |
22,040
+11,500
| +109% | +$269K | ﹤0.01% | 1960 |
|
|
2013
Q2 | $227K | Buy |
+10,540
| New | +$227K | ﹤0.01% | 2179 |
|
Other funds holding VIVO
IC
MF
AQR Capital Management's VIVO Position: Q3 2022 in Review
AQR Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 15,722 shares — an estimated $478K sold.
AQR Capital Management first reported a position in VIVO in Q2 2013 and held it in 33 quarters. The position peaked at $3.03M in Q2 2020. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.
- AQR Capital Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
- AQR Capital Management sold 15,722 Meridian Bioscience Inc shares in Q3 2022, an estimated $478K.
- AQR Capital Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 33 quarters.
- AQR Capital Management's Meridian Bioscience Inc position peaked at $3.03M in Q2 2020.
- 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.
Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.